{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:14:06Z","timestamp":1785575646057,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1136\/ijgc-2024-005336","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T12:35:34Z","timestamp":1713789334000},"page":"817-823","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-0396","authenticated-orcid":false,"given":"Mayuri","family":"Charnalia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaahid","family":"Mulani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Popat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmita","family":"Rath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Thomeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3232-6139","authenticated-orcid":false,"given":"Prachi","family":"Mittal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankita","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-6346","authenticated-orcid":false,"given":"Ingrid","family":"Boere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6742-6378","authenticated-orcid":false,"given":"Sudeep","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remi A","family":"Nout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2024-005336_bb0010","author":"National Comprehensive Cancer Network (US)","year":"2019","journal-title":"NCCN clinical practice guidelines in oncology. Cervical cancer, version 4"},{"key":"10.1136\/ijgc-2024-005336_bb0015","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00428-018-2362-9","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"472","author":"Cibula","year":"2018","journal-title":"Virchows Arch"},{"key":"10.1136\/ijgc-2024-005336_bb0020","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1001\/jamaoncol.2017.5179","article-title":"Cisplatin chemoradiotherapy vs radiotherapy in FIGO stage IIIB squamous cell carcinoma of the uterine cervix: a randomized clinical trial","volume":"4","author":"Shrivastava","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2024-005336_bb0025","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1200\/JCO.2017.75.9985","article-title":"Neoadjuvant chemotherapy followed by radical surgery versus concomitant chemotherapy and radiotherapy in patients with stage Ib2, IIA, or IIB squamous cervical cancer: a randomized controlled trial","volume":"36","author":"Gupta","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005336_bb0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/jamaoncol.2020.7168","article-title":"Effectiveness of sequential chemoradiation vs concurrent chemoradiation or radiation alone in adjuvant treatment after hysterectomy for cervical cancer: the STARS phase 3 randomized clinical trial","volume":"7","author":"Huang","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1136\/ijgc-2024-005336_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S1470-2045(20)30753-1","article-title":"MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study","volume":"22","author":"P\u00f6tter","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2024-005336_bb0040","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1200\/JCO.20.02530","article-title":"Late toxicity after adjuvant conventional radiation versus image-guided intensity-modulated radiotherapy for cervical cancer (PARCER): a randomized controlled trial","volume":"39","author":"Chopra","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1136\/ijgc-2024-005336_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055765","article-title":"Concurrent chemoradiation and brachytherapy alone or in combination with Nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial","volume":"12","author":"Chopra","year":"2022","journal-title":"BMJ Open"},{"key":"10.1136\/ijgc-2024-005336_bb0050","unstructured":"Embrace II protocol . n.d.Available: https:\/\/www.embracestudy.dk\/UserUpload\/PublicDocuments\/EMBRACE%20II%20Protocol.pdf"},{"key":"10.1136\/ijgc-2024-005336_bb0055","author":"ClinicalTrials.gov","year":"2018"},{"key":"10.1136\/ijgc-2024-005336_bb0060","author":"ClinicalTrials.gov","year":"2019"},{"key":"10.1136\/ijgc-2024-005336_bb0065","author":"ClinicalTrials.gov","year":"2019"},{"key":"10.1136\/ijgc-2024-005336_bb0070","author":"ClinicalTrials.gov","year":"2019"},{"key":"10.1136\/ijgc-2024-005336_bb0075","author":"ClinicalTrials.gov","year":"2020"},{"key":"10.1136\/ijgc-2024-005336_bb0080","author":"ClinicalTrials.gov","year":"2021"},{"key":"10.1136\/ijgc-2024-005336_bb0085","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1136\/ijgc-2024-005336_bb0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijgo.2009.02.009","article-title":"Revised FIGO staging for carcinoma of the cervix","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynecol Obstet"},{"key":"10.1136\/ijgc-2024-005336_bb0095","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstet"},{"key":"10.1136\/ijgc-2024-005336_bb0100","first-page":"287","article-title":"The new (version 9) American joint committee on cancer tumor, node, metastasis staging for cervical cancer","volume":"71","author":"Olawaiye","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2024-005336_bb0105","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2003.12.038","article-title":"Lymph node control in cervical cancer","volume":"59","author":"Grigsby","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-2024-005336_bb0110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/jrr\/rrt097","article-title":"Impact of boost irradiation on pelvic lymph node control in patients with cervical cancer","volume":"55","author":"Wakatsuki","year":"2014","journal-title":"J Radiat Res"},{"key":"10.1136\/ijgc-2024-005336_bb0115","article-title":"STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies","volume":"351","author":"Bossuyt","year":"2015","journal-title":"BMJ"},{"key":"10.1136\/ijgc-2024-005336_bb0120","first-page":"1121","article-title":"Clinical endpoints in oncology-a primer","volume":"11","author":"Delgado","year":"2021","journal-title":"Am J Cancer Res"},{"key":"10.1136\/ijgc-2024-005336_bb0125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.12701\/yujm.2019.00143","article-title":"Clinical significance of lymph node size in locally advanced cervical cancer treated with concurrent chemoradiotherapy","volume":"36","author":"Oh","year":"2019","journal-title":"Yeungnam Univ J Med"},{"key":"10.1136\/ijgc-2024-005336_bb0130","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semradonc.2018.11.002","article-title":"Management of nodal disease in advanced cervical cancer","volume":"29","author":"J\u00fcrgenliemk-Schulz","year":"2019","journal-title":"Semin Radiat Oncol"},{"key":"10.1136\/ijgc-2024-005336_bb0135","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1148\/radiol.2541090361","article-title":"Lymphatic metastases from pelvic tumors: anatomic classification, characterization, and staging","volume":"254","author":"McMahon","year":"2010","journal-title":"Radiology"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24014245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2024-005336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:30:03Z","timestamp":1753234203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24014245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S1048891X24014245"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2024-005336","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RECIST 1.1 versus clinico-radiological response assessment for locally advanced cervical cancer: implications on interpreting survival outcomes of future trials","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2024-005336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2024. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}